openPR Logo
Press release

Anesthesia and Respiratory Devices Market Outlook: Market to Reach US$ 93.92 Billion by 2033 at 6.6% CAGR; North America Leads with 40% Share; Key Players Include GE HealthCare, Medtronic, and Philips

12-23-2025 01:41 PM CET | Health & Medicine

Press release from: DataM intelligence 4 Market Research LLP

Anesthesia and Respiratory Devices

Anesthesia and Respiratory Devices

Global Anesthesia and Respiratory Devices Market reached US$ 54 billion in 2024 and is expected to expand to US$ 93.92 billion by 2033, growing at a CAGR of 6.6% during the forecast period 2025-2033. The market is witnessing steady growth driven by the rising volume of surgical procedures, increasing prevalence of respiratory disorders such as COPD, asthma, and sleep apnea, and the growing aging population requiring advanced respiratory support. Expanding access to healthcare services, particularly in emerging economies, along with the increasing adoption of minimally invasive surgeries, is further fueling demand for anesthesia delivery systems and respiratory care devices across hospitals, ambulatory surgical centers, and homecare settings.

Anesthesia and respiratory devices play a critical role in modern healthcare by ensuring patient safety and comfort during surgical, diagnostic, and critical care procedures. Anesthesia devices administer controlled mixtures of anesthetic agents and oxygen to maintain unconsciousness and pain management, while respiratory devices such as ventilators, oxygen concentrators, and pulse oximeters support or regulate breathing in patients with compromised respiratory function. Continuous technological advancements are improving device efficiency, portability, connectivity, and monitoring accuracy, thereby enhancing clinical outcomes. For example, in August 2024, Prevounce Health launched the Pylo OX1-LTE, a clinically validated, cellular-connected blood oxygen monitoring device designed for remote patient monitoring in chronic respiratory conditions such as COPD and asthma. Such innovations, combined with the growing adoption of remote and home-based care models, are expected to sustain strong growth in the anesthesia and respiratory devices market over the forecast period.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/anesthesia-and-respiratory-devices-market?sai-v

The Anesthesia and Respiratory Devices Market is the sector that develops and supplies medical devices used to administer anesthesia and support or manage patient breathing during surgical and critical care procedures.

Key Developments
✅ October 2025: Hospitals in North America used anesthesia machines, ventilators, and respiratory monitoring devices during surgical procedures and critical care management.

✅ September 2025: European healthcare facilities deployed anesthesia delivery systems and respiratory support devices across operating rooms and intensive care units.

✅ August 2025: Asia-Pacific hospitals utilized mechanical ventilators, anesthesia workstations, and breathing circuits for perioperative and respiratory care.

✅ July 2025: Medical device manufacturers enhanced anesthesia and respiratory devices with integrated monitoring, alarms, and safety features.

✅ May 2025: Ambulatory surgical centers adopted compact anesthesia machines and portable respiratory devices for outpatient procedures.

✅ March 2025: Regulatory authorities conducted evaluations of anesthesia and respiratory devices for safety, performance, and clinical compliance.

Mergers & Acquisitions
✅ November 2025: A global medical device company acquired an anesthesia equipment manufacturer to expand its respiratory and perioperative care portfolio.

✅ August 2025: A European respiratory device manufacturer partnered with a hospital network to supply anesthesia and ventilation systems.

✅ June 2025: An Asia-Pacific medical technology company acquired a respiratory care devices firm to strengthen its critical care equipment offerings.

Key Players
GE HealthCare | Medtronic | Teleflex Incorporated | Koninklijke Philips N.V. | Drägerwerk AG & Co. KGaA | Getinge AB | Smiths Group plc | Fisher & Paykel Healthcare Limited | ResMed | Inogen, Inc.

Emerging Players
Aerin Medical | Circadia Health | SeaStar Medical

Key Highlights

GE HealthCare - Holds a share of 19.2 percent: Leads the market with advanced anesthesia workstations, ventilators, and patient monitoring systems, supported by strong hospital penetration and global service networks.

Medtronic - Holds a share of 17.6 percent: Maintains a strong position through a broad portfolio of anesthesia, ventilation, and airway management devices, combined with continuous product innovation.

Koninklijke Philips N.V. - Holds a share of 14.8 percent: Drives growth with integrated respiratory care solutions, non-invasive ventilation systems, and digital-enabled critical care platforms.

Drägerwerk AG & Co. KGaA - Holds a share of 13.1 percent: Well-established provider of anesthesia machines and ventilators, recognized for reliability, safety standards, and strong presence in critical care settings.

Teleflex Incorporated - Holds a share of 9.6 percent: Specializes in airway management and respiratory care devices, benefiting from strong adoption in operating rooms and emergency care environments.

Getinge AB - Holds a share of 8.4 percent: Strengthens its market position with anesthesia systems, ICU ventilators, and infection control solutions tailored for hospitals and surgical centers.

Fisher & Paykel Healthcare Limited - Holds a share of 7.2 percent: Focused on respiratory humidification and non-invasive ventilation technologies, with growing demand in acute and home care settings.

Smiths Group plc - Holds a share of 5.4 percent: Contributes through advanced airway devices and respiratory safety technologies used across critical and emergency care applications.

ResMed - Holds a share of 3.1 percent: Primarily active in sleep apnea and home respiratory care devices, supporting the shift toward long-term and home-based respiratory management.

Inogen, Inc. - Holds a share of 1.6 percent: Niche player specializing in portable oxygen concentrators, addressing rising demand for mobility-focused respiratory solutions.

Emerging Player Highlights

Aerin Medical - Emerging presence: Develops minimally invasive ENT and airway solutions aimed at improving breathing disorders and outpatient care outcomes.

Circadia Health - Emerging presence: Focuses on contactless respiratory monitoring technologies for early detection and management of respiratory conditions.

SeaStar Medical - Emerging presence: Works on innovative extracorporeal and organ support technologies, contributing to advanced critical care respiratory solutions.

Purchase this report before year-end and unlock an exclusive 30% discount: https://www.datamintelligence.com/buy-now-page?report=anesthesia-and-respiratory-devices-market?sai-v
(Purchase 2 or more Reports and get 50% discount.)

Market Drivers
- Rising surgical procedure volumes globally, including elective and emergency surgeries requiring anesthesia support.

- Increasing prevalence of respiratory diseases such as asthma, COPD, pneumonia, and sleep apnea.

- Growing demand for advanced anesthesia delivery systems and patient monitoring solutions.

- Expansion of critical care and emergency departments with integrated respiratory support technologies.

- Advancements in ventilators, anesthesia workstations, and non-invasive respiratory devices.

- Rising healthcare expenditure and investment in modern hospital infrastructure.

- Focus on improving patient safety, clinical outcomes, and perioperative care.

Industry Developments
- Launch of next-generation anesthesia machines with digital integration and automated workflows.

- Development of advanced mechanical ventilators, high-flow oxygen systems, and non-invasive respiratory support devices.

- Integration of smart monitoring, AI-assisted decision support, and tele-monitoring features.

- Growth of portable and compact respiratory devices for home healthcare and emergency response.

- Rising partnerships between device manufacturers and healthcare providers to expand service coverage.

- Increased mergers, acquisitions, and strategic investments in anesthesia and respiratory technology portfolios.

- Enhanced focus on clinician training programs, simulation systems, and device interoperability.

Regional Insights
North America - 40% share: "Driven by high surgical procedure volume, advanced hospital infrastructure, strong adoption of innovative anesthesia and respiratory technologies, and supportive reimbursement."

Europe - 30% share: "Supported by structured healthcare systems, growing respiratory disease prevalence, emphasis on perioperative care quality, and increasing ICU capacity."

Asia Pacific - 24% share: "Fueled by expanding healthcare access, rising surgical and respiratory care demand, investments in critical care infrastructure, and growing awareness of modern devices."

Latin America - 4% share: "Boosted by improving healthcare services, expanding surgical capacity, and gradual adoption of advanced anesthesia and respiratory solutions."

Middle East & Africa - 2% share: "Driven by healthcare modernization initiatives, increasing critical care needs, and investments in emergency and perioperative technologies."

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/anesthesia-and-respiratory-devices-market?sai-v

Key Segments
By Respiratory Equipment
Respiratory equipment holds a significant share of the market, driven by rising prevalence of respiratory disorders, increasing surgical procedures, and growing demand for ventilatory support in critical care settings. Devices such as ventilators, oxygen concentrators, and CPAP/BiPAP systems are widely adopted across hospitals and homecare environments. Technological advancements, including portable and smart respiratory devices, continue to support segment growth.

By Respiratory Disposables
Respiratory disposables represent a steadily growing segment due to their frequent replacement, infection control requirements, and expanding patient pool requiring respiratory support. Products such as breathing circuits, masks, filters, and tubing are essential in both acute and chronic care settings. Increasing focus on patient safety, hygiene standards, and single-use medical products further drives demand in this segment.

By Respiratory Measurement Devices
Respiratory measurement devices account for a notable share of the market, supported by growing emphasis on accurate diagnosis, monitoring, and management of respiratory conditions. Devices including spirometers, capnographs, pulse oximeters, and peak flow meters are widely used in hospitals, diagnostic centers, and outpatient settings. Rising awareness of early disease detection and continuous patient monitoring contributes to segment expansion.

By Anesthesia Machines
Anesthesia machines form a core segment of the market, driven by the increasing volume of surgical procedures and advancements in anesthesia delivery systems. Modern anesthesia workstations offering integrated monitoring, enhanced safety features, and digital connectivity are gaining widespread adoption. Demand is further supported by growth in ambulatory surgical centers and the need for efficient perioperative care.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Anesthesia and Respiratory Devices Market Outlook: Market to Reach US$ 93.92 Billion by 2033 at 6.6% CAGR; North America Leads with 40% Share; Key Players Include GE HealthCare, Medtronic, and Philips here

News-ID: 4326626 • Views:

More Releases from DataM intelligence 4 Market Research LLP

Carbon Capture and Sequestration Market to Grow at 13.5% CAGR Through 2031, Driven by Net-Zero Targets and Industrial Decarbonization | DataM Intelligence
Carbon Capture and Sequestration Market to Grow at 13.5% CAGR Through 2031, Driv …
According to DataM Intelligence, the global Carbon Capture and Sequestration (CCS) Market is expected to grow at a CAGR of 13.5% during the forecast period 2024-2031. This growth is driven by accelerating global net-zero commitments, tightening carbon emission regulations, rising investments in low-carbon technologies, and increasing adoption of CCS across hard-to-abate industries including oil & gas, power generation, cement, steel, and chemicals. Get a Free Sample PDF Of This Report (Get
Lipid Disorder Treatment Market Outlook: Market to Reach US$ 41.2 Billion by 2033 at 5.0% CAGR; North America Leads with 42% Share; Key Players Include Pfizer, Novartis, and AstraZeneca
Lipid Disorder Treatment Market Outlook: Market to Reach US$ 41.2 Billion by 203 …
Global Lipid Disorder Treatment Market reached US$ 26.8 billion in 2024 and is expected to reach US$ 41.2 billion by 2033, growing at a CAGR of 5.0% during the forecast period 2025-2033. The market growth is driven by the increasing prevalence of lipid metabolism disorders such as hypercholesterolemia and dyslipidemia, which are major risk factors for cardiovascular diseases including heart attack and stroke. The market includes a variety of therapeutic classes
Food Probiotics Market Poised for 6.5% Growth Through 2031, Driven by Functional Foods Demand and Gut Health Awareness | DataM Intelligence
Food Probiotics Market Poised for 6.5% Growth Through 2031, Driven by Functional …
According to DataM Intelligence, the Global Food Probiotics Market reached USD 60.5 billion in 2022 and is expected to reach USD 100.1 billion by 2031, growing at a CAGR of 6.5% during the forecast period 2024-2031. Market growth is driven by rising consumer awareness of gut health, increasing consumption of functional foods and beverages, growing demand for preventive healthcare, and expanding applications of probiotics across human and animal nutrition. Get a
AI in Nutraceuticals Market Set to Reach US$ 2.48 Billion by 2032, Driven by Personalized Nutrition and Data-Driven Innovation | DataM Intelligence
AI in Nutraceuticals Market Set to Reach US$ 2.48 Billion by 2032, Driven by Per …
According to DataM Intelligence, the global AI in nutraceuticals market reached US$ 1.32 billion in 2024 and is expected to reach US$ 2.48 billion by 2032, growing at a CAGR of 8.19% during the forecast period 2025-2032. Market growth is driven by increasing demand for personalized nutrition, rising integration of AI and machine learning in product formulation, quality assurance, and supply chain optimization, and the growing adoption of digital health

All 5 Releases


More Releases for Respiratory

Prevalence Of Respiratory Diseases Fuels Demand For Respiratory Disposables: Key …
The Respiratory Disposables Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Respiratory Disposables Market Size During the Forecast Period? The respiratory disposables market has seen rapid growth in recent years. It is expected to grow from $1.01 billion in 2024 to $1.15
Transforming the Respiratory Monitoring Devices Market in 2025: Rising Incidence …
What Is the Expected Size and Growth Rate of the Respiratory Monitoring Devices Market? The market size for respiratory monitoring devices has seen swift expansion in the recent past. The market's growth is projected to increase from $1.67 billion in 2024 to $1.87 billion in 2025, with a compound annual growth rate (CAGR) of 11.8%. A combination of factors such as the prevalence of respiratory ailments, an aging demographic, technological innovations,
Transforming the Respiratory Monitoring Devices Market in 2025: Rising Incidence …
What Is the Expected Size and Growth Rate of the Respiratory Monitoring Devices Market? The market size for respiratory monitoring devices has seen swift expansion in the recent past. The market's growth is projected to increase from $1.67 billion in 2024 to $1.87 billion in 2025, with a compound annual growth rate (CAGR) of 11.8%. A combination of factors such as the prevalence of respiratory ailments, an aging demographic, technological innovations,
Molecular Respiratory Panels Market: Enhancing Accuracy and Speed in Respiratory …
Introduction The global molecular respiratory panels market is rapidly evolving, driven by the need for faster, more accurate diagnostics in respiratory diseases. With respiratory infections and diseases becoming increasingly prevalent worldwide, accurate detection and timely diagnosis are critical to improving patient outcomes. Molecular respiratory panels, which utilize advanced molecular techniques like PCR (Polymerase Chain Reaction) and other nucleic acid-based methods, enable the rapid identification of pathogens responsible for respiratory conditions. These
Tackling Respiratory Challenges: Lower Respiratory Tract Therapeutics Market 202 …
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033. Lower Respiratory Tract Therapeutics Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance. The Market Size Is Expected To Reach $48.37 billion In
Respiratory Assist Devices Market - Breathing Uninterrupted: Innovating Respirat …
Newark, New Castle, USA - new report, titled Respiratory Assist Devices Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Respiratory Assist Devices market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Respiratory Assist Devices market. The report offers an overview of